ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$1.82
-0.07 (-3.70%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,388.5% upside
Low Target
$17.95
Average Target
$27.09
High Target
$27.14
Current Price
$1.82
Current
$1.82
$1.82
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Scenario Analysis
Bear Case
$17.95
886.3%
Low target
Base Case
$27.09
+1,388.5%
Avg target
Bull Case
$27.14
+1,391.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$6.95
-73.8% from high
52-Week Low
$1.21
+50.2% from low
Target vs 52W High
$27.09
+289.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |